Jules Stein Eye Institute / David Geffen School of Medicine
				
				Los Angeles, California 90095
We've found
        1 trials
        at this facility
      	
	Macular Telangiectasia Type 2 Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Determine the Safety and Efficacy of Renexus® in Macular Telangiectasia Type 2
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	